These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24937843)

  • 1. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides.
    Clerico A; Passino C; Franzini M; Emdin M
    Clin Chim Acta; 2015 Mar; 443():17-24. PubMed ID: 24937843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and emerging biomarkers of heart failure.
    Clerico A; Vittorini S; Passino C; Emdin M
    Crit Rev Clin Lab Sci; 2009; 46(3):107-28. PubMed ID: 19514904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old and new biomarkers of heart failure.
    Emdin M; Vittorini S; Passino C; Clerico A
    Eur J Heart Fail; 2009 Apr; 11(4):331-5. PubMed ID: 19329823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging biomarkers in heart failure.
    van Kimmenade RR; Januzzi JL
    Clin Chem; 2012 Jan; 58(1):127-38. PubMed ID: 22086968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure.
    Ibrahim NE; Januzzi JL
    Clin Chem; 2017 Jan; 63(1):211-222. PubMed ID: 28062619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
    Motiwala SR; Januzzi JL
    Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort.
    Brouwers FP; van Gilst WH; Damman K; van den Berg MP; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van der Harst P; de Boer RA
    Circ Heart Fail; 2014 Sep; 7(5):723-31. PubMed ID: 25057112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which biomarkers do clinicians need for diagnosis and management of heart failure with reduced ejection fraction?
    Pouleur AC
    Clin Chim Acta; 2015 Mar; 443():9-16. PubMed ID: 25447693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease.
    deFilippi CR; Herzog CA
    Clin Chem; 2017 Jan; 63(1):59-65. PubMed ID: 27811207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expert consensus on the usefulness of natriuretic peptides in heart failure.].
    Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P
    Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Biomarkers for Acute Myocardial Infarction and Heart Failure.
    Wang XY; Zhang F; Zhang C; Zheng LR; Yang J
    Biomed Res Int; 2020; 2020():2018035. PubMed ID: 32016113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for developing biomarkers of heart failure.
    Jortani SA; Prabhu SD; Valdes R
    Clin Chem; 2004 Feb; 50(2):265-78. PubMed ID: 14656906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of biomarkers in chronic heart failure.
    Ahmad T; O'Connor CM
    Clin Pharmacol Ther; 2013 Oct; 94(4):468-79. PubMed ID: 23856627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
    Nagarajan V; Tang WH
    Congest Heart Fail; 2011; 17(4):169-74. PubMed ID: 21790966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current and Potential Clinical Relevance of Heart Failure Biomarkers.
    Gandhi PU; Testani JM; Ahmad T
    Curr Heart Fail Rep; 2015 Oct; 12(5):318-27. PubMed ID: 26280466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.